| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
TOTC: 3176 |
| Security Type |
Ordinary / Common Shares |
| Lead Underwriter |
To Be Announced |
| Days In Registration |
50 |
| Date Filed |
2-Sep-2008 |
| Form Filed | - |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
Medigen Biotechnology Corp is a biotechnology company, headquartered in Taiwan. It is principally engaged in the research and development in the field of biopharmaceuticals for liver diseases and cancers. The company was founded in 1999. |
| Revenue |
$4.2M |
| Net Income |
$1.3M |
| Shares Outstanding (post-offering) |
- |
| Contact |
- |
| Number of Employees |
35 |
|
| Original Filing Information |
| US |
| Shares Filed |
- |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
- |
| File Amount |
- |
| File Price Range |
- - - |
| File Mid Price |
- |
|
